Gauthier-Coles, Gregory http://orcid.org/0000-0002-4725-5313
Vennitti, Jade
Zhang, Zhiduo
Comb, William C.
Xing, Shuran
Javed, Kiran
Bröer, Angelika
Bröer, Stefan http://orcid.org/0000-0002-8040-1634
Funding for this research was provided by:
Department of Education and Training | Australian Research Council (DP180101702)
Article History
Received: 8 December 2020
Accepted: 13 August 2021
First Online: 6 September 2021
Competing interests
: AXA2678 is an amino acid mixture developed by Axcella Health. W.C.C. and S.X. are owners of Axcella Health stock and stock options. The remaining authors have no competing interests.